NCT06012656 is a clinical trial of MiniMAX in Primary Osteoarthritis, sponsored by Medacta International SA.

Who is sponsoring NCT06012656?

NCT06012656 is sponsored by Medacta International SA.

What drugs are being tested in NCT06012656?

Interventions in NCT06012656: MiniMAX.

What condition does NCT06012656 study?

NCT06012656 studies Primary Osteoarthritis, Secondary Osteoarthritis, Traumatic Arthritis, Rheumatoid Arthritis, Congenital Hip Dysplasia, Avascular Necrosis, Fracture; Femur, Head.

Is NCT06012656 still recruiting?

NCT06012656 is currently active, enrolled. Last updated 29 September 2025.

Last reviewed 2025-09-29 · How we verify

NCT06012656

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

Active, enrolled Last updated 29 September 2025

What this trial tests

trial testing MiniMAX in Primary Osteoarthritis in 100 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 January 2019

Primary endpoint
2 January 2029

2 January 2031

Quick facts

Lead sponsor	Medacta International SA
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	100
Start date	2 January 2019
Primary completion	2 January 2029
Estimated completion	2 January 2031
Sites	1 location across France

Drugs / interventions tested

MiniMAX

Conditions studied

Primary Osteoarthritis — all drugs for Primary Osteoarthritis →
Secondary Osteoarthritis — all drugs for Secondary Osteoarthritis →
Traumatic Arthritis — all drugs for Traumatic Arthritis →
Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →

Sponsor

Medacta International SA — full company profile →

Who can join

18 and older, any sex, with Primary Osteoarthritis or Secondary Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a post-marketing surveillance on MiniMAX Stem

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Primary Osteoarthritis

Currently open trials in the same condition.

NCT05002335 — Clinical and Radiological Outcomes of Medacta Shoulder System (BE) · active not recruiting
NCT03357445 — AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study · NA · active not recruiting

Other Medacta International SA trials

Trials by the same sponsor.

NCT06775704 — Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System · recruiting
NCT06640764 — Multicentre SMS Study - FR · recruiting
NCT06578897 — A Post-Market, Retrospective Study on 3D Metal Tibial and Femoral Cones · completed
NCT05679232 — Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty · NA · recruiting
NCT05785364 — A Post Market Surveillance Study About the MONOCER Cup · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06012656 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medacta International SA
Last refreshed: 29 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06012656.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing